The World Health Organization (WHO) has approved a compensation plan for side effect claims among people in 92 poor countries for a coronavirus vaccine under COVAX, a global initiative aimed at equal access to a vaccine against COVID-19 and led by GAVI .
This development occurred after parties raised concerns about WHO’s lack of clarity regarding the handling of claims for compensation due to serious side effects of the COVID-19 vaccine.
According to the official statement, the WHO’s Compensation Compensation Plan is the first and only mechanism in the world to provide a fair and transparent process for people with adverse side effects from the coronavirus vaccine to apply for compensation.
Under the plan, applicants will be provided one-time error-free compensation in a full and firm agreement, greatly reducing the need for legal action that requires significant financial and time resources.
The plan will cover suspected serious side effects associated with the coronavirus vaccine, which will be submitted to eligible economies of the COVAX Advance Market Commitment (AMC), a group of 92 countries covering most of Africa and Southeast Asia, by June 30, 2022. to be distributed.
WHO plans to fund the AMC donor funding program initially as an additional fee for all doses of the COVID-19 vaccine distributed through COVAX.
Seth Berkeley, CEO of GAVI, which operates COVAX, said WHO’s compensation plan would benefit low-income countries and would prove to be a big boost for COVAX, which aims to ensure equal global access to the COVID-19 vaccine.